MBNL1 and myotonic dystrophy type 1: This observation prompted us to measure circMBNL1 in skeletal muscle biopsies and PBMCs of DM1 patients, where MBNL1 protein bioavailability is reduced by its sequestration in nuclear CUG-foci [9,10].